Allergy

In Allergy, `A new day has begun'
pp. 631-633(3)
Authors: Bousquet, J.; Bieber, T.; Fokkens, W.; Kowalski, M.; Humbert, M.; Niggemann, B.; Simon, H.-U.; Cruz, A.A.; Haahtela, T.

Finnish Allergy Programme 2008-2018 - time to act and change the course
pp. 634-645(12)
Authors: Haahtela, T.; von Hertzen, L.; Mäkelä, M.; Hannuksela, M.

House dust mite control measures for asthma: systematic review
pp. 646-659(14)
Authors: Gøtzsche, P. C.; Johansen, H. K.

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA²LEN Review
pp. 660-669(10)
Authors: Baiardini, I.; Braido, F.; Tarantini, F.; Porcu, A.; Bonini, S.; Bousquet, P.-J.; Zuberbier, T.; Demoly, P.; Canonica, G. W.

An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
pp. 670-684(15)
Authors: Sullivan, S. D.; Turk, F.

Mechanisms of asthma in Olympic athletes - practical implications
pp. 685-694(10)
Authors: Haahtela, T.; Malmberg, P.; Moreira, A.

A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells
pp. 695-702(8)
Authors: Laffer, S.; Lupinek, C.; Rauter, I.; Kneidinger, M.; Drescher, A.; Jordan, J.-H.; Krauth, M.-T.; Valent, P.; Kricek, F.; Spitzauer, S.; Englund, H.; Valenta, R.

Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1α
pp. 703-711(9)
Authors: Gaga, M.; Ong, Y.-E.; Benyahia, F.; Aizen, M.; Barkans, J.; Kay, A. B.

Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs
pp. 712-719(8)
Authors: Fernandez, T. D.; Mayorga, C.; Torres, M. J.; Cornejo-Garcia, J. A.; López, S.; Chaves, P.; Rondon, C.; Blanca, M.

Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
pp. 720-727(8)
Authors: Allam, J.-P.; Stojanovski, G.; Friedrichs, N.; Peng, W.; Bieber, T.; Wenzel, J.; Novak, N.

Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism
pp. 728-734(7)
Authors: Niebuhr, M.; Langnickel, J.; Draing, C.; Renz, H.; Kapp, A.; Werfel, T.

Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment
pp. 735-741(7)
Authors: Serrano, C.; Guilarte, M.; Tella, R.; Dalmau, G.; Bartra, J.; Gaig, P.; Cerdà, M.; Cardona, V.; Valero, A.

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
pp. 742-750(9)
Authors: Wollenberg, A.; Reitamo, S.; Atzori, F.; Lahfa, M.; Ruzicka, T.; Healy, E.; Giannetti, A.; Bieber, T.; Vyas, J.; Deleuran, M.

Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema
pp. 751-757(7)
Authors: Bork, K.; Staubach, P.; Hardt, J.

Characterization of Der p 21, a new important allergen derived from the gut of house dust mites
pp. 758-767(10)
Authors: Weghofer, M.; Dall'Antonia, Y.; Grote, M.; Stöcklinger, A.; Kneidinger, M.; Balic, N.; Krauth, M.-T.; Fernández-Caldas, E.; Thomas, W. R.; Hage, M. van; Vieths, S.; Spitzauer, S.; Horak, F.; Svergun, D. I.; Konarev, P. V.; Valent, P.; Thalhamer, J.; Keller, W.; Valenta, R.; Vrtala, S.

Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana
pp. 768-776(9)
Authors: Sudha, V. T.; Arora, N.; Gaur, S. N.; Pasha, S.; Singh, B. P.

How to assess disease activity in patients with chronic urticaria?
pp. 777-780(4)
Authors: Młynek, A.; Zalewska-Janowska, A.; Martus, P.; Staubach, P.; Zuberbier, T.; Maurer, M.

Do we have to recommend not using oat-containing emollients in children with atopic dermatitis?
pp. 781-782(2)
Authors: Goujon-Henry, C.; Hennino, A.; Nicolas, J.-F.

Response to Campbell, Spackman, Sullivan letter to Allergy
pp. 783-783(1)
Authors: Brown, R.; Turk, F.; Dale, P.; Bousquet, J.

Occupational allergy in a researcher due to Ole e 9, an allergenic 1,3-β-glucanase from olive pollen
pp. 784-785(2)
Authors: Palomares, O.; Fernández-Nieto, M.; Villalba, M.; Rodríguez, R.; Cuesta-Herranz, J.

Anaphylactic shock after intradermal testing with betalactam antibiotics
pp. 785-785(1)
Authors: Weber-Mani, U.; Pichler, W. J.

DRESS syndrome induced by sodium meglumine ioxitalamate
pp. 786-787(2)
Authors: Belhadjali, H.; Bouzgarrou, L.; Youssef, M.; Njim, L.; Zili, J.

Delayed hypersensitivity to acylureidopenicillins: a case report
pp. 787-789(3)
Authors: Gaeta, F.; Alonzi, C.; Valluzzi, R. L.; Viola, M.; Romano, A.

Localized cold-induced urticaria associated with specific immunotherapy for tree pollen allergy
pp. 789-790(2)
Authors: Ducommun, J.; Morel, V.; Ribi, C.; Hauser, C.

Omalizumab in persistent severe bakers' asthma
pp. 790-791(2)
Authors: Olivieri, M.; Biscardo, C. A.; Turri, S.; Perbellini, L.